Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. OMER has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
OMER stock price ended at $3.31 on Monday, after rising2.95%
The Omeros Corp stock price increased by 2.95% on the last trading day (19 May 2025), rising from 3.21 to 3.31. Throughout the last trading session, the stock experienced a fluctuation of 8.39% , ranging from a day low of $3.1 to a day high of 3.36. The price has declined in 6 of the last 10 days, resulting in a total change of -51.40% during this period. On the last day, trading volume increase by -915.92K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.09M shares were traded, amounting to approximately 6.69M.
OMER Technical Signals
OMER(Omeros Corp Corp) has 6 buy signals and 5 sell signals now. The current trend is consolidation starting from 2025-04-28. The total price change during this trend is -55.78%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of OMER over the last 5 trading days is 13.03M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
OMER Moving Average Analysis
Omeros Corp's overall moving average trend leans more bearish as of Tuesday, May 20, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $7.662149999999999, and $9.256999999999998. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.5018500000000006, and $0.9070000000000009. A break-down below any of these levels will issue sell signals.
OMER Short Selling Analysis
The short sale ratio of Omeros Corp(OMER) as of 12 May 2025 is 36.09%, rising from last trading day. With increasing price from 6.18 to 3.79. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
5
Buy
6
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
6 Bullish Signals
6 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Relative Strength Index (14 days)
RSI_14 < 30
23.318
Bullish
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
4.769
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-175.822
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
18.433
Bullish
Williams %R (14 days)
WILLR_14 < -80
-94.568
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
23.875
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-2.427
Bearish
Momentum (10 days)
MOM_10 < 0
-3.955
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.938
Bearish
Closing price
close < fibonacci_S1
3.215
Bearish
Moving Average
20-day SMA crosses below 250-day SMA
--
Bearish
OMER Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Omeros Corp(OMER), our algorithm predicts OMER's 1-month price at $3.09, with an -4.03%downwardshift. Using a similarity score up to 97.51%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Omeros Corp (OMER.O) stock, as of Sunday, May 18, 2025 , forecasts a -4.03% change over the next month, based on its high correlation with SCOR.O stock patterns. The similarity between their price movements over the analyzed periods is 97.51%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
OMER
No Data
SCOR
Down: -4.03%Similarity: 97.51%
Name
Similarity
Up/Down
SCOR.O
97.51%
-4.03%
FLYW.O
97.25%
-12.69%
LULU.O
97.23%
-10.05%
TDC.N
97.22%
-6.11%
GEG.O
97.16%
+22.96%
PI.O
96.94%
+10.03%
MAX.N
96.93%
-26.86%
HDSN.O
96.89%
+2.62%
NKE.N
96.87%
+4.51%
OMER Seasonality Analysis
Based on OMER's historical stock price data across all years, the probability of a positive return in May is27.27%, suggesting it maynotbe an ideal month to invest in OMER. In contrast,Novemberoffers the highest probability of positive returns at70.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Omeros Corp (OMER.O) stock in November has the highest probability of a positive return (70.00%), while September has the lowest probability (20.00%).
Performance Seasonality
The chart shows Omeros Corp. (OMER)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Omeros Corp (OMER.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. OMER has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Omeros Corp (OMER.O) stock in a year?
The radar chart shows that buying Omeros Corp (OMER.O) stock in November has the highest probability of a positive return (70.00%), while September has the lowest probability (20.00%).
How has Omeros Corp. (OMER)'s stock price performed over the past three years?
OMER's stock price rose by 31.85% in 2023,increased by 200.30% in 2024, and went down by 66.36% in 2025.
Bearish technical signals of OMER include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1, 20-day SMA crosses below 250-day SMA.
Is OMER a buy based on overall technical signals summary?
OMER has 6 buy signals and 5 sell signals now. Overall the technical rating for OMER is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of OMER.
What is the trend of Omeros Corp (OMER)'s moving average?
Omeros Corp's overall moving average trend leans more bearish as of May 20 2025, with 3 negative signals and 1 positive signal.
What is price prediction for OMER stock next month?
The price prediction chart for Omeros Corp (OMER.O) stock, as of May 18 2025, forecasts a -4.03% change over the next month, based on its high correlation with SCOR stock patterns. The similarity between their price movements over the analyzed periods is 97.51%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for OMER Stock?
OMER stock is predicted to reach **$9.20** by the end of 2025. This forecast is based on positive FDA developments for narsoplimab and oversold technical indicators.
What is price prediction 2030 for OMER Stock?
OMER stock is predicted to reach **$20 by 2030**, driven by potential FDA approval of narsoplimab and debt restructuring. The stock shows oversold conditions with low RSI and stochastic levels, suggesting a rebound. Successful drug commercialization could trigger significant growth.